GSK, Vir Biotech seek emergency use authorisation for COVID-19 antibody
Companies are requesting emergency approval of drug for the early treatment of COVID-19
Read More
Tag: Vir Biotechnology
GSK, Vir look beyond COVID-19 to develop new therapies for flu and other respiratory viruses
New agreement builds on existing collaboration to develop therapies for coronaviruses
Read More
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
Companies will collaborate on a combination therapy study
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
